188 related articles for article (PubMed ID: 19493021)
1. Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise.
Othman M; Powell S; Chirinian Y; Hegadorn C; Hopman W; Lillicrap D
Haemophilia; 2009 Sep; 15(5):1126-34. PubMed ID: 19493021
[TBL] [Abstract][Full Text] [Related]
2. New assays for monitoring haemophilia treatment.
Shima M; Matsumoto T; Ogiwara K
Haemophilia; 2008 Jul; 14 Suppl 3():83-92. PubMed ID: 18510527
[TBL] [Abstract][Full Text] [Related]
3. Variability of thromboelastographic responses following the administration of rFVIIa to haemophilia A dogs supports the individualization of therapy with a global test of haemostasis.
Othman M; Powell S; Hopman WM; Lillicrap D
Haemophilia; 2010 Nov; 16(6):919-25. PubMed ID: 20609015
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs.
Wiinberg B; Jensen AL; Rozanski E; Johansson PI; Kjelgaard-Hansen M; Tranholm M; Kristensen AT
Vet J; 2009 Jan; 179(1):121-9. PubMed ID: 17920966
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A.
Prasad S; Lillicrap D; Labelle A; Knappe S; Keller T; Burnett E; Powell S; Johnson KW
Blood; 2008 Jan; 111(2):672-9. PubMed ID: 17978172
[TBL] [Abstract][Full Text] [Related]
6. Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients.
Ghosh K; Shetty S; Kulkarni B
Haemophilia; 2007 Nov; 13(6):734-9. PubMed ID: 17973850
[TBL] [Abstract][Full Text] [Related]
7. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation.
Wiinberg B; Jensen AL; Johansson PI; Rozanski E; Tranholm M; Kristensen AT
J Vet Intern Med; 2008; 22(2):357-65. PubMed ID: 18346141
[TBL] [Abstract][Full Text] [Related]
8. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
Lewis SJ; Stephens E; Florou G; Macartney NJ; Hathaway LS; Knipping J; Collins PW
Br J Haematol; 2007 Sep; 138(6):775-82. PubMed ID: 17672884
[TBL] [Abstract][Full Text] [Related]
9. Global hemostasis in pregnancy: are we using thromboelastography to its full potential?
Othman M; Falcón BJ; Kadir R
Semin Thromb Hemost; 2010 Oct; 36(7):738-46. PubMed ID: 20978994
[TBL] [Abstract][Full Text] [Related]
10. Global hemostasis testing thromboelastography: old technology, new applications.
Chen A; Teruya J
Clin Lab Med; 2009 Jun; 29(2):391-407. PubMed ID: 19665684
[TBL] [Abstract][Full Text] [Related]
11. Thrombelastography in dogs admitted to an intensive care unit.
Wagg CR; Boysen SR; Bédard C
Vet Clin Pathol; 2009 Dec; 38(4):453-61. PubMed ID: 19548969
[TBL] [Abstract][Full Text] [Related]
12. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
13. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
Johansen RF; Sørensen B; Ingerslev J
Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
[TBL] [Abstract][Full Text] [Related]
14. [Hemostatic management in hemophilia A. Usefulness of APTT and TEG as a method for monitoring Factor VIII concentrates].
Watanabe S; Ito S; Igarashi S; Itamoto M; Harada N; Kanazawa M; Sato M; Yasukouji T
Shoni Shikagaku Zasshi; 1985; 23(3):760-8. PubMed ID: 3938858
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs.
Karpf DM; Kjalke M; Thim L; Agersø H; Merricks EP; Defriess N; Nichols TC; Ezban M
Haemophilia; 2011 Sep; 17(5):e963-8. PubMed ID: 21682818
[TBL] [Abstract][Full Text] [Related]
16. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.
Bassus S; Wegert W; Krause M; Escuriola-Ettinghausen C; Siegemund A; Petros S; Scholz T; Scharrer I; Kreuz W; Engelmann L; Kirchmaier CM
Platelets; 2006 Sep; 17(6):378-84. PubMed ID: 16973498
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cuticle bleeding time in canine haemophilia A.
Pijnappels MI; Briët E; van der Zwet GT; Huisden R; van Tilburg NH; Eulderink F
Thromb Haemost; 1986 Feb; 55(1):70-3. PubMed ID: 3085267
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of EC50 of factor VIII as predictor of prophylaxis efficacy in patients with severe haemophilia A.
Fernández-Bello I; Rode F; Álvarez-Román MT; Butta NV; Rivas-Muñoz S; Hernández-Moreno AL; de la Corte-Rodríguez H; Martín-Salces M; Larsen LF; Jiménez-Yuste V
Eur J Pharm Sci; 2019 Feb; 128():215-221. PubMed ID: 30529268
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia.
Kristensen AT; Wiinberg B; Jessen LR; Andreasen E; Jensen AL
J Vet Intern Med; 2008; 22(1):140-7. PubMed ID: 18289301
[TBL] [Abstract][Full Text] [Related]
20. Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography.
Young G; Blain R; Nakagawa P; Nugent DJ
Haemophilia; 2006 Nov; 12(6):598-604. PubMed ID: 17083509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
